Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sight Sciences (SGHT)
NASDAQ:SGHT
Holding SGHT?
Track your performance easily
SGHT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.04 - $8.45
Previous Close$6.83
Volume116.03K
Average Volume (3M)212.57K
Market Cap
$343.60M
Enterprise Value$259.19M
Total Cash (Recent Filing)$118.18M
Total Debt (Recent Filing)$33.77M
Price to Earnings (P/E)―
Beta2.48
Next Earnings
Nov 06, 2024EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding50,307,299
10 Day Avg. Volume186,945
30 Day Avg. Volume212,569
Standard Deviation0.31
R-Squared0.20
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.25
Price to Sales (P/S)4.33
Price to Cash Flow (P/CF)-9.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.26
Enterprise Value/Gross Profit3.75
Enterprise Value/Ebitda-7.44
Forecast
1Y Price Target
$7.38Price Target Upside12.50% Upside
Rating ConsensusHold
Number of Analyst Covering5
Sight Sciences News
PremiumCompany Announcements
Sight Sciences Unveils Investor Presentation for Future Talks
Bulls Say, Bears Say
Bulls Say
ReimbursementThe early TearCare reimbursement claims are encouraging.
RevenueSGHT beat consensus revenue in 1Q24 and management reiterated its 2024 revenue guidance, which likely proves conservative.
UtilizationOMNI utilization grew 10% and 5%, which suggests momentum is building.
Bears Say
Analyst RatingHold rating is maintained until there is more confidence in the durability of SGHT's potential double-digit revenue growth.
Financial PerformanceWhile encouraged by 2Q24, the analyst maintains a Hold rating.
Revenue GuidanceManagement lowered the mid-point of its 2024 revenue guidance as 4Q24 TearCare price increases likely dries up cash pay demand.
---
Ownership Overview
53.41% Insiders
10.47% Mutual Funds
13.18% Other Institutional Investors
22.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGHT FAQ
What was Sight Sciences’s price range in the past 12 months?
Sight Sciences lowest stock price was $1.04 and its highest was $8.45 in the past 12 months.
What is Sight Sciences’s market cap?
Currently, no data Available
When is Sight Sciences’s upcoming earnings report date?
Sight Sciences’s upcoming earnings report date is Nov 06, 2024 which is in 47 days.
How were Sight Sciences’s earnings last quarter?
Sight Sciences released its earnings results on Aug 01, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.296 by $0.046.
Is Sight Sciences overvalued?
According to Wall Street analysts Sight Sciences’s price is currently Undervalued.
Does Sight Sciences pay dividends?
Sight Sciences does not currently pay dividends.
What is Sight Sciences’s EPS estimate?
Sight Sciences’s EPS estimate is -$0.21.
How many shares outstanding does Sight Sciences have?
Sight Sciences has 50,307,300 shares outstanding.
What happened to Sight Sciences’s price movement after its last earnings report?
Sight Sciences reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.296. Following the earnings report the stock price went down -14.96%.
Which hedge fund is a major shareholder of Sight Sciences?
Among the largest hedge funds holding Sight Sciences’s share is EntryPoint Capital, LLC. It holds Sight Sciences’s shares valued at 35K.
---
Sight Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.38 (12.50% Upside)
$7.38 (12.50% Upside)
Hedge Fund Trend
Increased
By 5.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $219.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
97.97%
12-Months-Change
Fundamentals
Return on Equity
-44.01%
Trailing 12-Months
Asset Growth
-19.20%
Trailing 12-Months
Company Description
Sight Sciences
Sight Sciences Inc is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. The company's product portfolio features the OMNI Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and viscoelastic delivery. The company's non-surgical product portfolio consists of TearCare system which is commercially available for both ophthalmologists and optometrists.
---
SGHT Company Deck
---
SGHT Earnings Call
Q2 2024
0:00 / 0:00
---
SGHT Stock 12 Month Forecast
Average Price Target
$7.38
▲(12.50% Upside)
Technical Analysis
Best Analysts Covering SGHT
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+54.61%
assigned a buy rating 7 months ago
Copying Thomas Stephan's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +54.61% per trade.
---